Mulenga PL - Search Results

1

Combination HIV prevention during pregnancy and the post-partum period in Malawi and Zambia: a mathematical modelling analysis.

Powers KA, Mutale W, Rosenberg NE, Graybill LA, Mollan KR, Freeborn K, Saidi F, Maman S, Mulenga PL, Jahn A, Nyirenda RK, Stringer JSA, Vermund SH, Chi BH. Powers KA, et al. Among authors: mulenga pl. J Int AIDS Soc. 2023 Jul;26(7):e26128. doi: 10.1002/jia2.26128. J Int AIDS Soc. 2023. PMID: 37403422 Free PMC article.

2

CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia.

Chi BH, Giganti M, Mulenga PL, Limbada M, Reid SE, Mutale W, Stringer JS. Chi BH, et al. Among authors: mulenga pl. J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):125-31. doi: 10.1097/QAI.0b013e3181ab6d8b. J Acquir Immune Defic Syndr. 2009. PMID: 19546812 Free PMC article.

3

A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics.

Koethe JR, Westfall AO, Luhanga DK, Clark GM, Goldman JD, Mulenga PL, Cantrell RA, Chi BH, Zulu I, Saag MS, Stringer JS. Koethe JR, et al. Among authors: mulenga pl. PLoS One. 2010 Mar 12;5(3):e9680. doi: 10.1371/journal.pone.0009680. PLoS One. 2010. PMID: 20300631 Free PMC article. Clinical Trial.

4

Effect of Enhanced Adherence Package on Early ART Uptake Among HIV-Positive Pregnant Women in Zambia: An Individual Randomized Controlled Trial.

Mubiana-Mbewe M, Bosomprah S, Kadota JL, Koyuncu A, Kusanathan T, Mweebo K, Musokotwane K, Mulenga PL, Chi BH, Vinikoor MJ. Mubiana-Mbewe M, et al. Among authors: mulenga pl. AIDS Behav. 2021 Mar;25(3):992-1000. doi: 10.1007/s10461-020-03060-4. Epub 2020 Oct 8. AIDS Behav. 2021. PMID: 33033996 Free PMC article. Clinical Trial.

5

Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.

Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, Reid SE, Bolton-Moore C, Chintu N, Mulenga PL, Stringer EM, Sheneberger R, Mwaba P, Stringer JS. Chi BH, et al. Among authors: mulenga pl. J Acquir Immune Defic Syndr. 2010 May 1;54(1):63-70. doi: 10.1097/QAI.0b013e3181c6c65c. J Acquir Immune Defic Syndr. 2010. PMID: 20009765 Free PMC article.

6

Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study.

Stringer JS, Mwango AJ, Giganti MJ, Mulenga L, Levy JW, Stringer EM, Mulenga P, Saag MS, Musonda P, Williams FB, Reid SE, Chi BH. Stringer JS, et al. Int J Epidemiol. 2012 Apr;41(2):448-59. doi: 10.1093/ije/dys022. Int J Epidemiol. 2012. PMID: 22493326 Free PMC article.

7

Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia.

Giganti MJ, Limbada M, Mwango A, Moyo C, Mulenga LB, Guffey MB, Mulenga PL, Bolton-Moore C, Stringer JS, Chi BH. Giganti MJ, et al. Among authors: mulenga pl. J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):120-3. doi: 10.1097/QAI.0b013e31825da11d. J Acquir Immune Defic Syndr. 2012. PMID: 22659648 Free PMC article.

8

Predictors of patient attrition according to different definitions for loss to follow-up: a comparative analysis from Lusaka, Zambia.

Li MS, Musonda P, Gartland M, Mulenga PL, Mwango A, Stringer JS, Chi BH. Li MS, et al. Among authors: mulenga pl. J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):e116-9. doi: 10.1097/QAI.0b013e31828d2802. J Acquir Immune Defic Syndr. 2013. PMID: 23760096 Free PMC article. No abstract available.

9

Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia.

Jo Y, Jamieson L, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, Haimbe P, Mukumbwa-Mwenechanya M, Mulenga PL, Nichols BE, Rosen S. Jo Y, et al. Among authors: mulenga pl. PLoS One. 2023 Mar 14;18(3):e0280748. doi: 10.1371/journal.pone.0280748. eCollection 2023. PLoS One. 2023. PMID: 36917568 Free PMC article.

10

Insulin Resistance is Associated with Higher Plasma Viral Load Among HIV-Positive Adults Receiving Longer-Term (1 Year) Combination Antiretroviral Therapy (ART).

Mulenga LB, Musonda P, Chirwa L, Siwingwa M, Mweemba A, Suwilanji S, Fwoloshi S, Phiri H, Phiri D, Mulenga PL, Chisenga T, Nsakanya R, Shibemba A, Todd J, Nzala S, Kaile T, Kankasa C, Hachaambwa L, Claassen C, Sikazwe I, Koethe JR, Sinkala E, Heimburger DC, Wester CW. Mulenga LB, et al. Among authors: mulenga pl. J Infect Dis Ther. 2019;7(4):406. Epub 2019 Aug 16. J Infect Dis Ther. 2019. PMID: 35538928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page